Fig. 1 · Structure
Documents & Downloads
Anticancer agent 265
Anticancer Compound
Anticancer agent 265 is a novel anticancer compound that targets malignant cells. This agent demonstrates significant in vitro anticancer activity against human bone cancer cell lines, specifically U2OS, Saos-2, and GC9811, with IC50 values of 13.1 μM, 11.7 μM, and 14.6 μM, respectively. Its efficacy makes it a valuable tool for research into bone cancer therapeutics and mechanisms of resistance.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 184177-83-1 |
| Applications | Anticancer Compound |
| Formula | C30H35N5O3 |
| Molecular Weight | 513.63 |
| SMILES | O=C1N(C2=CC=C(N3CCN(C4=CC=C(O)C=C4)CC3)C=C2)C=NN1[C@@H](CC)[C@@H](OCC5=CC=CC=C5)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.